294 related articles for article (PubMed ID: 29621732)
21. Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease.
Pandey MK; Burrow TA; Rani R; Martin LJ; Witte D; Setchell KD; Mckay MA; Magnusen AF; Zhang W; Liou B; Köhl J; Grabowski GA
Nature; 2017 Mar; 543(7643):108-112. PubMed ID: 28225753
[TBL] [Abstract][Full Text] [Related]
22. Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a--C5aR1 Pathway.
Bisht K; Canesin G; Cheytan T; Li M; Nemeth Z; Csizmadia E; Woodruff TM; Stec DE; Bulmer AC; Otterbein LE; Wegiel B
J Immunol; 2019 May; 202(10):2982-2990. PubMed ID: 30952817
[TBL] [Abstract][Full Text] [Related]
23. The role of C5a in acute lung injury induced by highly pathogenic viral infections.
Wang R; Xiao H; Guo R; Li Y; Shen B
Emerg Microbes Infect; 2015 May; 4(5):e28. PubMed ID: 26060601
[TBL] [Abstract][Full Text] [Related]
24. A Novel Role for C5a in B-1 Cell Homeostasis.
Bröker K; Figge J; Magnusen AF; Manz RA; Köhl J; Karsten CM
Front Immunol; 2018; 9():258. PubMed ID: 29520270
[TBL] [Abstract][Full Text] [Related]
25. The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells.
Wiese AV; Ender F; Quell KM; Antoniou K; Vollbrandt T; König P; Köhl J; Laumonnier Y
PLoS One; 2017; 12(9):e0184956. PubMed ID: 28931049
[TBL] [Abstract][Full Text] [Related]
26. A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models.
Benson MJ; Thomas NK; Talwar S; Hodson MP; Lynch JW; Woodruff TM; Borges K
Neurobiol Dis; 2015 Apr; 76():87-97. PubMed ID: 25681535
[TBL] [Abstract][Full Text] [Related]
27. The C5a/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia/reperfusion injury.
Peng Q; Wu W; Wu KY; Cao B; Qiang C; Li K; Sacks SH; Zhou W
Kidney Int; 2019 Jul; 96(1):117-128. PubMed ID: 31029505
[TBL] [Abstract][Full Text] [Related]
28. Targeting Complement C5a Receptor 1 for the Treatment of Immunosuppression in Sepsis.
Sommerfeld O; Medyukhina A; Neugebauer S; Ghait M; Ulferts S; Lupp A; König R; Wetzker R; Schulz S; Figge MT; Bauer M; Press AT
Mol Ther; 2021 Jan; 29(1):338-346. PubMed ID: 32966769
[TBL] [Abstract][Full Text] [Related]
29. Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.
Ajona D; Zandueta C; Corrales L; Moreno H; Pajares MJ; Ortiz-Espinosa S; Martínez-Terroba E; Perurena N; de Miguel FJ; Jantus-Lewintre E; Camps C; Vicent S; Agorreta J; Montuenga LM; Pio R; Lecanda F
Am J Respir Crit Care Med; 2018 May; 197(9):1164-1176. PubMed ID: 29327939
[TBL] [Abstract][Full Text] [Related]
30. Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice.
Mihai S; Hirose M; Wang Y; Thurman JM; Holers VM; Morgan BP; Köhl J; Zillikens D; Ludwig RJ; Nimmerjahn F
Front Immunol; 2018; 9():535. PubMed ID: 29616034
[TBL] [Abstract][Full Text] [Related]
31. Bidirectional Crosstalk between C5a Receptors and the NLRP3 Inflammasome in Macrophages and Monocytes.
Haggadone MD; Grailer JJ; Fattahi F; Zetoune FS; Ward PA
Mediators Inflamm; 2016; 2016():1340156. PubMed ID: 27382187
[TBL] [Abstract][Full Text] [Related]
32. Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses.
Kim AH; Dimitriou ID; Holland MC; Mastellos D; Mueller YM; Altman JD; Lambris JD; Katsikis PD
J Immunol; 2004 Aug; 173(4):2524-9. PubMed ID: 15294968
[TBL] [Abstract][Full Text] [Related]
33. C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta.
Hernandez MX; Namiranian P; Nguyen E; Fonseca MI; Tenner AJ
ASN Neuro; 2017 Feb; 9(1):1759091416687871. PubMed ID: 28078911
[TBL] [Abstract][Full Text] [Related]
34. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
[TBL] [Abstract][Full Text] [Related]
35. PA-X-associated early alleviation of the acute lung injury contributes to the attenuation of a highly pathogenic H5N1 avian influenza virus in mice.
Hu J; Mo Y; Gao Z; Wang X; Gu M; Liang Y; Cheng X; Hu S; Liu W; Liu H; Chen S; Liu X; Peng D; Liu X
Med Microbiol Immunol; 2016 Aug; 205(4):381-95. PubMed ID: 27289459
[TBL] [Abstract][Full Text] [Related]
36. The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Virus Infection.
Traboulsi H; Cloutier A; Boyapelly K; Bonin MA; Marsault É; Cantin AM; Richter MV
Antimicrob Agents Chemother; 2015 Oct; 59(10):6317-27. PubMed ID: 26248373
[TBL] [Abstract][Full Text] [Related]
37. Saikosaponin A inhibits influenza A virus replication and lung immunopathology.
Chen J; Duan M; Zhao Y; Ling F; Xiao K; Li Q; Li B; Lu C; Qi W; Zeng Z; Liao M; Liu Y; Chen W
Oncotarget; 2015 Dec; 6(40):42541-56. PubMed ID: 26637810
[TBL] [Abstract][Full Text] [Related]
38. A Novel Bifunctional Fusion Protein, Vunakizumab-IL22, for Protection Against Pulmonary Immune Injury Caused by Influenza Virus.
Han L; Shi C; Zeng X; Cen L; Mei X; Fan J; Ju D; Zhu H
Front Immunol; 2021; 12():727941. PubMed ID: 34504501
[TBL] [Abstract][Full Text] [Related]
39. Complement C5aR1 Signaling Promotes Polarization and Proliferation of Embryonic Neural Progenitor Cells through PKCζ.
Coulthard LG; Hawksworth OA; Li R; Balachandran A; Lee JD; Sepehrband F; Kurniawan N; Jeanes A; Simmons DG; Wolvetang E; Woodruff TM
J Neurosci; 2017 May; 37(22):5395-5407. PubMed ID: 28455369
[TBL] [Abstract][Full Text] [Related]
40. The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets.
Nording H; Baron L; Haberthür D; Emschermann F; Mezger M; Sauter M; Sauter R; Patzelt J; Knoepp K; Nording A; Meusel M; Meyer-Saraei R; Hlushchuk R; Sedding D; Borst O; Eitel I; Karsten CM; Feil R; Pichler B; Erdmann J; Verschoor A; Chavakis E; Chavakis T; von Hundelshausen P; Köhl J; Gawaz M; Langer HF
Nat Commun; 2021 Jun; 12(1):3352. PubMed ID: 34099640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
